Prescription Opioid Abuse, Prescription Opioid Addiction, and Heroin Abuse Among Adolescents in a Recovery High School: A Pilot Study

References

• Bieber, C. M., Fernandez, K., Borsook, D., Brennan, M. J., Butler, S. F., Jamison, R. N.,… Katz, N. P. (2008). Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: A pilot case-control study. Experimental and Clinical Psychopharmacology, 16(5), 429–434. doi: 10.1037/1064-1297.16.5.429
   PubMed Web of Science ®Google Scholar
• Boyd, C. J., & McCabe, S. E. (2008). Coming to terms with the nonmedical use of prescription medications. Substance Abuse Treatment, Prevention, and Policy, 3, 22. doi: 10.1186/1747-597x-3-22
   PubMed Web of Science ®Google Scholar
• Boyd, C. J., McCabe, S. E., & Teter, C. J. (2006). Medical and nonmedical use of prescription pain medication by youth in a Detroit-area public school district. Drug and Alcohol Dependence, 81(1), 37–45. doi: 10.1016/j.drugalcdep.2005.05.017
   PubMed Web of Science ®Google Scholar
• Broadus, A. D., Hartje, J. A., Roget, N. A., Cahoon, K. L., & Clinkinbeard, S. S. (2010). Attitudes about addiction: A national study of addiction educators. Journal of Drug Education, 40(3), 281–298. doi: 10.2190/de.40.3.e
   PubMed Web of Science ®Google Scholar
• Cicero, T. J., Ellis, M. S., & Surratt, H. L. (2012). Effect of abuse-deterrent formulation of OxyContin. The New England Journal of Medicine, 367(2), 187–189. doi: 10.1056/nejmc1204141
   PubMed Web of Science ®Google Scholar
• Cichewicz, D. L. (2004). Synergistic interactions between cannabinoid and opioid analgesics. Life Sciences, 74(11), 1317–1324. doi: 10.1016/j.lfs.2003.09.038
   PubMed Web of Science ®Google Scholar
• Compton, W. M., & Volkow, N. D. (2006). Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence, 81(2), 103–107. doi: 10.1016/j.drugalcdep.2005.05.009
   PubMed Web of Science ®Google Scholar
• Conrod, P. J., Castellanos-Ryan, N., & Strang, J. (2010). Brief, personality-targeted coping skills interventions and survival as a non-drug user over a 2-year period during adolescence. Archives of General Psychiatry, 67(1), 85–93. doi: 10.1001/archgenpsychiatry.2009.173
   PubMed Web of Science ®Google Scholar
• Grau, L. E., Dasgupta, N., Harvey, A. P., Irwin, K., Givens, A., Kinzly, M. L., & Heimer, R. (2007). Illicit use of opioids: is OxyContin a “gateway drug”? The American Journal on Addictions, 16(3), 166–173. doi: 10.1080/10550490701375293
   PubMed Web of Science ®Google Scholar
• Hamed, E., & Moe, D. (2010). Development of tamper formulations: State of the pharmaceutical industry. Current Drug Abuse Reviews, 3(3), 139–146. doi: 10.2174/1874473711003030139
   PubMedGoogle Scholar
• Kandel, D. (1975). Stages in adolescent involvement in drug use. Science, 190(4217), 912–914. doi: 10.1126/science.1188374
   PubMed Web of Science ®Google Scholar
• Katz, N. (2008). Abuse-deterrent opioid formulations: Are they a pipe dream? Current Rheumatology Reports, 10(1), 11–18. doi: 10.1007/s11926-008-0003-z
   PubMedGoogle Scholar
• McCabe, S. E., Boyd, C. J., & Teter, C. J. (2005). Illicit use of opioid analgesics by high school seniors. Journal of Substance Abuse Treatment, 28(3), 225–230. doi: 10.1016/j.jsat.2004.12.009
   PubMed Web of Science ®Google Scholar
• McCabe, S. E., & Cranford, J. A. (2012). Motivational subtypes of nonmedical use of prescription medications: Results from a national study. Journal of Adolescent Health, 51(5), 445–452. doi: 10.1016/j.jadohealth.2012.02.004
   PubMed Web of Science ®Google Scholar
• McCabe, S. E., West, B. T., Cranford, J. A., Ross-Durow, P., Young, A., Teter, C. J., & Boyd, C. J. (2011). Medical misuse of controlled medications among adolescents. Archives of Pediatric and Adolescent Medicine, 165(8), 729–735.
   PubMed Web of Science ®Google Scholar
• McCabe, S. E., West, B. T., Teter, C. J., & Boyd, C. J. (2012). Co-ingestion of prescription opioids and other drugs among high school seniors: Results from a national study. Drug and Alcohol Dependence, 126(1–2), 65–70. doi: 10.1016/j.drugalcdep.2012.04.017
   PubMed Web of Science ®Google Scholar
• Meier, E. A., Troost, J. P., & Anthony, J. C. (2012). Extramedical use of prescription pain relievers by youth aged 12 to 21 years in the United States: National estimates by age and by year. Archives of Pediatric & Adolescent Medicine, 166(9), 803–807. doi: 10.1001/archpediatrics.2012.209
   PubMed Web of Science ®Google Scholar
• Merrill, J. C., Kleber, H. D., Shwartz, M., Liu, H., & Lewis, S. R. (1999). Cigarettes, alcohol, marijuana, other risk behaviors, and American youth. Drug and Alcohol Dependence, 56(3), 205–212. doi: 10.1016/s0376-8716(99)00034-4
   PubMed Web of Science ®Google Scholar
• Moberg, D. P., & Finch, A. J. (2008). Recovery High Schools: A descriptive study of school programs and students. Journal of Groups in Addiction & Recovery, 2, 128–161. doi: 10.1080/15560350802081314
   PubMedGoogle Scholar
• Muhuri, P. D., Gfroerer, J. C., & Davies, M. C. (2013). Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBHSQ Data Review, August, 1–17. Retrieved from www.samhsa.gov/data
   Google Scholar
• Office of Applied Studies. (2005). Results from the 2004 national survey on drug use and health: National findings ( DHHS Publication No. SMA 05-4062, NSDUH Series H-28). Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Osgood, E. D., Eaton, T. A., Trudeau, J. J., & Katz, N. P. (2012). A brief survey to characterize oxycodone abuse patterns in adolescents enrolled in two substance abuse recovery high schools. American Journal of Drug and Alcohol Abuse, 38(2), 166–170. doi: 10.3109/00952990.2011.643994
   PubMed Web of Science ®Google Scholar
• Paulozzi, L. J. (2012). Prescription drug overdoses: A review. Journal of Safety Research, 43, 283–289. doi: 10.1016/j.jsr.2012.08.009
   PubMed Web of Science ®Google Scholar
• Raffa, R. B., & Pergolizzi, J. V., Jr.. (2010). Opioid formulations designed to resist/deter abuse. Drugs, 70(13), 1657–1675. doi: 10.2165/11537940-000000000-00000
   PubMed Web of Science ®Google Scholar
• Reisfield, G. M. (2010). Medical cannabis and chronic opioid therapy. Journal of Pain and Palliative Care Pharmacotherapy, 24(4), 356–361. doi: 10.3109/15360288.2010.519431
   PubMedGoogle Scholar
• Rogers, P. D., & Copley, L. (2009). The nonmedical use of prescription drugs by adolescents. Adolescent Medicine: State of the Art Reviews, 20(1), 1–8.
   PubMedGoogle Scholar
• Russell, B. S., Leland, A. J., Trudeau, J. J., & Thompson, A. (in press). Social influence on adolescent polysubstance use: The escalation to opioid use. Substance Use & Misuse.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2013). Results from the 2012 National Survey on Drug Use and Health: Summary of national findings ( NSDUH Series H-46, HHS Publication No. SMA 13-4795). Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Sung, H. E., Richter, L., Vaughan, R., Johnson, P. B., & Thom, P. (2005). Nonmedical use of prescription opioids among teenagers in the United States: Trends and correlates. Journal of Adolescent Health, 37(1), 44–51. doi: 10.1016/j.jadohealth.2005.02.013
   PubMed Web of Science ®Google Scholar
• Vanyukov, M. M., Tarter, R. E., Kirillova, G. P., Kirisci, L., Reynolds, M. D., Kreek, M. J.,… Ridenour, T. A. (2012). Common liability to addiction and “gateway hypothesis”: Theoretical, empirical, and evolutionary perspective. Drug and Alcohol Dependence, 123(Suppl 1), S3–S17. doi: 10.1016/j.drugalcdep.2011.12.018
   PubMedGoogle Scholar
• Vosburg, S. K., Jones, J. D., Manubay, J. M., Ashworth, J. B., Benedek, I. H., & Comer, S. D. (2012). Assessment of a formulation designed to be crush-resistant in prescription opioid abusers. Drug and Alcohol Dependence, 126(1–2), 206–215. doi: 10.1016/j.drugalcdep.2012.05.013
   PubMed Web of Science ®Google Scholar
• Vosburg, S. K., Jones, J. D., Manubay, J. M., Ashworth, J. B., Shapiro, D. Y., & Comer, S. D. (2013). A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin(R) (non-TRF) in prescription opioid abusers. Addiction, 108(6), 1095–1106. doi: 10.1111/add.12114
   PubMed Web of Science ®Google Scholar
• Young, A., McCabe, S. E., Cranford, J. A., Ross-Durow, P., & Boyd, C. J. (2012). Nonmedical use of prescription opioids among adolescents: Subtypes based on motivation for use. Journal of Addictive Diseases, 31(4), 332–341. doi: 10.1080/10550887.2012.735564
   PubMed Web of Science ®Google Scholar
• Zacny, J. P., & Lichtor, S. A. (2008). Nonmedical use of prescription opioids: Motive and ubiquity issues. The Journal of Pain, 9(6), 473–486. doi: 10.1016/j.jpain.2007.12.008
   PubMed Web of Science ®Google Scholar